Alnylam Pharmaceuticals, Inc.
ALNY
$221.20
$4.221.95%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 15.77% | 14.32% | 7.94% | -2.00% | 8.87% |
| Total Receivables | 60.95% | 111.46% | 91.85% | 172.65% | 83.25% |
| Inventory | 35.46% | 28.12% | 5.36% | -0.79% | -14.64% |
| Prepaid Expenses | 105.12% | 58.84% | 141.01% | 29.37% | -4.80% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 26.80% | 29.10% | 22.92% | 17.80% | 14.84% |
|
|
|||||
| Total Current Assets | 26.80% | 29.10% | 22.92% | 17.80% | 14.84% |
| Net Property, Plant & Equipment | 6.55% | 1.67% | 2.04% | -1.46% | -3.25% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -12.62% | -18.81% | -17.21% | 40.69% | 89.69% |
| Total Assets | 21.74% | 21.73% | 17.13% | 15.38% | 13.88% |
|
|
|||||
| Total Accounts Payable | 5.49% | 30.01% | 30.88% | 66.08% | 38.41% |
| Total Accrued Expenses | 19.26% | 34.41% | 17.10% | 21.93% | 13.64% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 112.02% | 113.72% | 71.45% | 20.95% | 38.60% |
| Total Finance Division Other Current Liabilities | -97.05% | -97.80% | 9.16% | 74.28% | 96.88% |
| Total Other Current Liabilities | -97.05% | -97.80% | 9.16% | 74.28% | 96.88% |
| Total Current Liabilities | 16.27% | 25.46% | 23.61% | 27.43% | 23.27% |
|
|
|||||
| Total Current Liabilities | 16.27% | 25.46% | 23.61% | 27.43% | 23.27% |
| Long-Term Debt | 4.25% | 4.85% | 5.05% | 1.35% | 0.27% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -6.22% | -5.23% | -1.94% | -5.34% | -6.23% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -97.81% | -98.22% | -98.09% | 25.37% | 18.60% |
| Total Liabilities | -2.57% | -1.08% | 0.10% | 10.67% | 7.54% |
|
|
|||||
| Common Stock & APIC | 0.34% | 1.32% | 1.66% | 2.13% | 7.97% |
| Retained Earnings | 14.56% | 11.55% | 8.03% | 0.60% | -4.50% |
| Treasury Stock & Other | -7.30% | 33.65% | 41.78% | 12.29% | 13.53% |
| Total Common Equity | 440.37% | 831.59% | 1,076.33% | 622.92% | 8,270.56% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 440.37% | 831.59% | 1,076.33% | 622.92% | 8,270.56% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 440.37% | 831.59% | 1,076.33% | 622.92% | 8,270.56% |
|
|
|||||